A Resource for Healthcare and Social Services Professionals
August 28, 2023
12:00 pm–12:30 pm ET
This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.
Event sold-out
Via Zoom
AUD Series: These trainings will provide an overview of alcohol use disorders, evidence-based screening tools, brief negotiated interview (BNI) for alcohol consumption, management of AUD in the primary care setting, and medications for the treatment of alcohol use disorder.
This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.
Nurses, social workers, other clinical staff, and non-clinicians.
Dr. Peterkin is board certified in internal medicine and addiction medicine. She received her medical degree from New York Medical College and completed residency in Internal Medicine at Mount Auburn Hospital in Cambridge, MA. As a graduate of the Grayken Addiction Medicine Fellowship, her interests include addiction education and expanding access to substance use disorder treatment. She works as a hospitalist, regularly attends on the inpatient addiction consult service and works in Faster Paths which is Boston Medical Center’s low barrier substance use disorder clinic. She currently serves as Program Director for the Grayken Addiction Medicine Fellowship, Co-Director of the Addiction and Health Track in the LEADS course at the Boston University Chobanian & Avedisian School of Medicine and works on a NIDA-funded clinical trial as a medical clinician.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (BSAS/DPH)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete and return the evaluation and stay for the entire session will be awarded 0.50 contact hours.
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
Grayken Center for Addiction TTA is approved to offer LADC/CADCs and recovery coaches who complete this course 0.50 general continuing education credits.
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
Event sold-out